Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Praveen Neeli

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Biomedicines|June 26, 2026
In Vivo mRNA-Lipid Nanoparticle CAR-T Cell Engineering: Advances, Challenges, and Clinical TranslationVipin K Yadav, Priyanka Yadav, Sreevidya Mallappa, et al.
Frontiers in Public Health|February 23, 2026
Editorial: Leveraging information systems and artificial intelligence for public health advancementsChin-Ling Chen, Chenxi Huang, Mueen Uddin, et al.
International Journal of Molecular Sciences|September 13, 2025
DNA Vaccines in the Post-mRNA Era: Engineering, Applications, and Emerging InnovationsPraveen Neeli, Dafei Chai, Debanjana Roy, et al.
Iscience|October 30, 2024
Erratum: Comparison of DNA vaccines with AddaS03 as an adjuvant and an mRNA vaccine against SARS-CoV-2Praveen Neeli, Dafei Chai, Xu Wang, et al.
Iscience|June 26, 2023
Comparison of DNA vaccines with AddaS03 as an adjuvant and an mRNA vaccine against SARS-CoV-2Praveen Neeli, Dafei Chai, Xu Wang, et al.
Frontiers in Physiology|December 5, 2022
C1QBP regulates mitochondrial plasticity to impact tumor progression and antitumor immune responseQiping Wang, Dafei Chai, Navid Sobhani, et al.
Genes & Diseases|April 1, 2024
DNA-delivered monoclonal antibodies targeting the p53 R175H mutant epitope inhibit tumor development in miceDafei Chai, Xu Wang, Praveen Neeli, et al.
Cancer Letters|May 23, 2026
Nanoplasmid PSMA DNA vaccine primes antitumor immunity and enhances response to PD-1 blockade against prostate cancerPerry Ayn Mayson A Maza, Leslie Flores, Dana Cyril-Ramirez, et al.
Frontiers in Oncology|August 18, 2023
AI-powered discovery of a novel p53-Y220C reactivatorShan Zhou, Dafei Chai, Xu Wang, et al.
Iscience|March 7, 2023
HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8<sup>+</sup>T cell immune response and elicits potential therapeutic effect in hepatocellular carcinomaXiaoqing Shi, Jiage Ding, Yanyan Zheng, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Biomedicines|June 26, 2026
In Vivo mRNA-Lipid Nanoparticle CAR-T Cell Engineering: Advances, Challenges, and Clinical TranslationVipin K Yadav, Priyanka Yadav, Sreevidya Mallappa, et al.
Frontiers in Public Health|February 23, 2026
Editorial: Leveraging information systems and artificial intelligence for public health advancementsChin-Ling Chen, Chenxi Huang, Mueen Uddin, et al.
International Journal of Molecular Sciences|September 13, 2025
DNA Vaccines in the Post-mRNA Era: Engineering, Applications, and Emerging InnovationsPraveen Neeli, Dafei Chai, Debanjana Roy, et al.
Iscience|October 30, 2024
Erratum: Comparison of DNA vaccines with AddaS03 as an adjuvant and an mRNA vaccine against SARS-CoV-2Praveen Neeli, Dafei Chai, Xu Wang, et al.
Iscience|June 26, 2023
Comparison of DNA vaccines with AddaS03 as an adjuvant and an mRNA vaccine against SARS-CoV-2Praveen Neeli, Dafei Chai, Xu Wang, et al.
Frontiers in Physiology|December 5, 2022
C1QBP regulates mitochondrial plasticity to impact tumor progression and antitumor immune responseQiping Wang, Dafei Chai, Navid Sobhani, et al.
Genes & Diseases|April 1, 2024
DNA-delivered monoclonal antibodies targeting the p53 R175H mutant epitope inhibit tumor development in miceDafei Chai, Xu Wang, Praveen Neeli, et al.
Cancer Letters|May 23, 2026
Nanoplasmid PSMA DNA vaccine primes antitumor immunity and enhances response to PD-1 blockade against prostate cancerPerry Ayn Mayson A Maza, Leslie Flores, Dana Cyril-Ramirez, et al.
Frontiers in Oncology|August 18, 2023
AI-powered discovery of a novel p53-Y220C reactivatorShan Zhou, Dafei Chai, Xu Wang, et al.
Iscience|March 7, 2023
HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8<sup>+</sup>T cell immune response and elicits potential therapeutic effect in hepatocellular carcinomaXiaoqing Shi, Jiage Ding, Yanyan Zheng, et al.
Pageof 2